Parkview Health

Dr. Neil Sharma Joins Peak Gastroenterology Associates in Colorado Springs

Retrieved on: 
Monday, January 8, 2024
Oncology, Health, Hospitals, Other Health, Managed Care, Radiology, Endoscopy, Faculty, ASGE, Physician, Research, CME, DDW, MD, University, ACG, GI, Medical college, Gastroenterology, Peak, Internal medicine, Assistant, Patient, Sharma, Parkview Health, Commission, Nursing

Peak Gastroenterology Associates (“Peak” or “the Company”), the largest provider of gastroenterology and related ancillary diagnostic and therapeutic services in Colorado, today welcomed Neil Sharma, MD, one of the nation’s leading board-certified, fellowship-trained interventional gastroenterologists and endoscopists.

Key Points: 
  • Peak Gastroenterology Associates (“Peak” or “the Company”), the largest provider of gastroenterology and related ancillary diagnostic and therapeutic services in Colorado, today welcomed Neil Sharma, MD, one of the nation’s leading board-certified, fellowship-trained interventional gastroenterologists and endoscopists.
  • Dr. Sharma will lead Peak’s interventional program in Colorado Springs, Colorado.
  • Dr. Sharma joins Peak from Parkview Health, northeast Indiana’s largest not-for-profit healthcare provider, where he served for over 10 years, most recently as the first President of the Parkview Cancer Institute, which he helped to conceive and develop.
  • He went on to pursue an additional fellowship in Interventional Endoscopy at the University of North Carolina, Chapel Hill.

MATTER opens applications for accelerator focused on reducing maternal mortality in the U.S.

Retrieved on: 
Tuesday, December 12, 2023
Pharmaceutical, Health Technology, Health Insurance, Research, Parenting, Healthcare Reform, Public Policy, Government, Hospitals, Baby, Maternity, Fitness & Nutrition, Clinical Trials, University, Education, Biotechnology, Women, Professional Services, Health, Practice Management, Vitamins, Supplements, General Health, Science, Consumer, Social Services, Other Health, Health Care Service Corporation, Infant, Parkview Health, Incidence, Prenatal care, BayCare Ballpark, Mortality, Pregnancy, Mentorship, Death, Labs, HCSC, Mother, Risk, Organon, Dietary supplement

MATTER , the premier healthcare incubator and innovation hub, has opened applications for the second 51 Labs , an accelerator focused on women’s health.

Key Points: 
  • MATTER , the premier healthcare incubator and innovation hub, has opened applications for the second 51 Labs , an accelerator focused on women’s health.
  • This year’s program focuses on preventing maternal mortality in the U.S. before, during and after birth and receives support from Health Care Service Corporation , Laerdal Million Lives Fund , BayCare , Parkview Health , University of Chicago Medicine , Organon and Stryker .
  • While all ages and races saw an increase in maternal mortality in 2021, many inequities still exist due to a variety of factors, including but not limited to access to quality care, socioeconomic status, race and education level.
  • The second cohort of the 51 Labs accelerator will address the question:
    How can we prevent maternal mortality in the U.S. before, during and after birth?

Interim Results from a NanOlogy Phase 2 Clinical Trial of its Intratumoral Investigational Drug in the Treatment of Locally Advanced Pancreatic Cancer

Retrieved on: 
Tuesday, October 10, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Immunosuppression, TME, Pancreatitis, SOC, Cedars-Sinai Medical Center, AACR, Standard of care, LAPC, University, Survival, Disease, Abdominal pain, Nausea, University of Illinois College of Medicine, Immunotherapy, Pancreatic cancer, LSAM, Immunomodulation, Paclitaxel, Plasma, Parkview Health, Illinois College, Tumor necrosis factor, Tissue, NK, Phenotype, Blood, Conference, Research, Pharmaceutical industry, Dietary supplement, Vaccine, Medical device, Medical imaging, Pancreas, MD, Safety

The research article entitled Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and Clinical Outcome provides safety and response data from dose escalation and 2-injection cohorts.

Key Points: 
  • The research article entitled Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and Clinical Outcome provides safety and response data from dose escalation and 2-injection cohorts.
  • “Pancreatic cancer is among the most lethal cancers with 5-year survival of only 12%,” said lead investigator and author, Neil Sharma, MD.
  • The research article reports data from evaluable subjects in the first two cohorts while the third is pending final readout.
  • Additionally, two posters presented downstaging and immune data from the Phase 2 trial following IT LSAM-PTX at the recent AACR Special Conference on Pancreatic Cancer.

KeyCare Partners with Parkview Health to Offer Patients 24x7 Virtual Care via Epic-based Platform

Retrieved on: 
Wednesday, August 30, 2023
Senior, Record, Hospital, Digital health, Patient, Physician, Diagnosis, Parkview Health, MD

CHICAGO, Aug. 30, 2023 /PRNewswire/ -- KeyCare, the nation's first and only Epic-based virtual care company, announced today that it is partnering with Parkview Health to offer patients anytime, anywhere access to virtual urgent care with licensed providers who will share clinical notes with a patient's regular provider. Parkview Health patients can obtain virtual urgent care by scheduling a visit whenever and wherever they need through Parkview's MyChart patient portal.  

Key Points: 
  • CHICAGO, Aug. 30, 2023 /PRNewswire/ -- KeyCare , the nation's first and only Epic-based virtual care company, announced today that it is partnering with Parkview Health to offer patients anytime, anywhere access to virtual urgent care with licensed providers who will share clinical notes with a patient's regular provider.
  • Parkview Health patients can obtain virtual urgent care by scheduling a visit whenever and wherever they need through Parkview's MyChart patient portal.
  • "Parkview Health patients can now be confident that when they obtain care from a KeyCare Virtualist provider, their most up-to-date and accurate health information will be shared between their virtual and regular physicians."
  • These Virtualist healthcare providers have secure access to a patient's Parkview Health data while delivering care and completing encounter details on KeyCare's Epic platform.

NRC Health unveils winners of 2023 patient experience and loyalty awards

Retrieved on: 
Tuesday, August 8, 2023
New England Aquarium, New England, Success, Marital status, Mayo Clinic Hospital (Rochester), University, Beth Israel Deaconess Medical Center, National Research Corporation, Patient experience, NRC, Hospital, Health, Human, Sea, Organization, NPS, Hospital of the University of Pennsylvania, Missouri Baptist Medical Center, Community hospital, Monterey Peninsula, UC, The Christ Hospital, UC Davis Health Stadium, Patient, Lahey Hospital & Medical Center, California Hospital Medical Center, Christ Hospital, Parkview Health, Pharmaceutical industry, Nursing, Mercy, Troy

LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.

Key Points: 
  • LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.
  • NRC Health's Consumer Loyalty Award winners lead the way in delivering exceptional patient experiences.
  • Elevating the patient experience remains a priority in healthcare, and NRC Health's 2023 Excellence in Patient Experience Award winners have demonstrated outstanding commitment to individualized and human-centered care.
  • To check whether your local hospital is a 2023 honoree, see the full lists of winning organizations for both the 2023 Consumer Loyalty Awards and the 2023 Excellence in Patient Experience Awards .

NRC Health unveils winners of 2023 patient experience and loyalty awards

Retrieved on: 
Tuesday, August 8, 2023
New England Aquarium, New England, Success, Marital status, Mayo Clinic Hospital (Rochester), University, Beth Israel Deaconess Medical Center, National Research Corporation, Patient experience, NRC, Hospital, Health, Human, Sea, Organization, NPS, Hospital of the University of Pennsylvania, Missouri Baptist Medical Center, Community hospital, Monterey Peninsula, UC, The Christ Hospital, UC Davis Health Stadium, Patient, Lahey Hospital & Medical Center, California Hospital Medical Center, Christ Hospital, Parkview Health, Pharmaceutical industry, Nursing, Mercy, Troy

LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.

Key Points: 
  • LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.
  • NRC Health's Consumer Loyalty Award winners lead the way in delivering exceptional patient experiences.
  • Elevating the patient experience remains a priority in healthcare, and NRC Health's 2023 Excellence in Patient Experience Award winners have demonstrated outstanding commitment to individualized and human-centered care.
  • To check whether your local hospital is a 2023 honoree, see the full lists of winning organizations for both the 2023 Consumer Loyalty Awards and the 2023 Excellence in Patient Experience Awards .

Supply & Demand Chain Executive Awards Parkview Health and Tecsys with 2023 Top Supply Chain Project Award for Bringing Pharmacy Supply Chain into the Future

Retrieved on: 
Tuesday, June 27, 2023
Demand, Partnership, Pharming, MBA, Forecasting, Automation, Patient, Parkview Health, Health, Parkview, Retail, Pharmaceutical industry

FORT WAYNE, Ind., June 27, 2023 /PRNewswire/ -- Tecsys, a leader in supply chain management software, and Parkview Health, a prominent Indiana-based health system, have been jointly recognized by Supply & Demand Chain Executive as winners of this year's Top Supply Chain Projects Award for their groundbreaking supply chain transformation project integrating pharmaceuticals into the broader healthcare product supply chain processes. The award profiles innovative case study-type projects designed to automate, optimize, streamline and improve the supply chain.

Key Points: 
  • FORT WAYNE, Ind., June 27, 2023 /PRNewswire/ -- Tecsys, a leader in supply chain management software, and Parkview Health, a prominent Indiana-based health system, have been jointly recognized by Supply & Demand Chain Executive as winners of this year's Top Supply Chain Projects Award for their groundbreaking supply chain transformation project integrating pharmaceuticals into the broader healthcare product supply chain processes.
  • The synchronization between Parkview Health's pharmacy, and the broader healthcare supply chain has yielded significant and ongoing results.
  • "By partnering with Parkview Health, we combined our leading-edge supply chain expertise with a highly skilled team to set a new benchmark for the future of healthcare supply chain."
  • Go to www.SDCExec.com/awards to learn more about upcoming Supply & Demand Chain Executive awards.

SECTRA TO IMPLEMENT ENTERPRISE IMAGING SAAS IN THE CLOUD WITH PARKVIEW HEALTH

Retrieved on: 
Thursday, April 20, 2023
Cloud, Parkview Health, Azure, Software as a service, Hospital, International, Microsoft, Microsoft Azure, Parkview, Radiology, VNA, Software, Medical imaging, Sectra AB

SHELTON, Conn. , April 20, 2023 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will implement its enterprise imaging cloud subscription service, Sectra One Cloud, at Parkview Health.

Key Points: 
  • SHELTON, Conn. , April 20, 2023 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will implement its enterprise imaging cloud subscription service, Sectra One Cloud, at Parkview Health.
  • This will allow the Indiana-based health system future scalability as imaging volumes grow and will ensure data security in a fully managed cloud environment.
  • "This is an exciting time for Parkview Health to be positioned for success in the forefront of an industry transformation to cloud.
  • The Sectra One Cloud subscription model provides access to the full Sectra product portfolio while ensuring an easy and predictable cost model to grow enterprise imaging volumes," says Isaac Zaworski, president of Sectra Inc.

Sectra to implement enterprise imaging SaaS in the cloud with Parkview Health in the US

Retrieved on: 
Thursday, April 20, 2023
Cloud, Software as a service, International, Microsoft, KLAS, Radiology, Conn, VNA, Hospital, Microsoft Azure, Parkview Health, Azure, Parkview, Software, Medical imaging, Sectra AB

LINKÖPING,Sweden and SHELTON,Conn., April 20, 2023 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will implement its enterprise imaging cloud subscription service, Sectra One Cloud, at Parkview Health in the US.

Key Points: 
  • LINKÖPING,Sweden and SHELTON,Conn., April 20, 2023 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will implement its enterprise imaging cloud subscription service, Sectra One Cloud, at Parkview Health in the US.
  • This will allow the Indiana-based health system future scalability as imaging volumes grow and will ensure data security in a fully managed cloud environment.
  • "This is an exciting time for Parkview Health to be positioned for success in the forefront of an industry transformation to cloud.
  • The Sectra One Cloud subscription model provides access to the full Sectra product portfolio while ensuring an easy and predictable cost model to grow enterprise imaging volumes," says Isaac Zaworski, president of Sectra Inc.

FDB Marks Achievements in Optimizing Medication CDS through a Patient-Centric Approach at HIMSS23

Retrieved on: 
Thursday, April 13, 2023
Electronic prescribing, UMS, Children's Medical Safety Research Institute, McCormick Place, Pharmacy, Genomics, Health care, Hospital, Level 5, Reduction, CST, First Databank, FDB, Zynx Health, Level 4, Organization, Pharmacotherapy, CDS, Community, Abrazo Community Health Network, Patient, Patient safety, Drug combination, Reading, SAN, Exhibition, Knowledge, Ecosystem, Parkview Health, Health, Hand, Lehigh Valley Health Network, Hyperkalemia, Safety, Conference, Nursing, Pharmaceutical industry, Nightclub, United States Department of Agriculture South Building, Geography of Indiana

SOUTH SAN FRANCISCO, Calif., April 13, 2023 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, will have a strong presence at the 2023 HIMSS Global Health Conference & Exhibition in Chicago, April 17-20, with a focus on FDB PatientFirst™ solutions. FDB will be showcasing how these solutions are helping hospitals and health systems optimize medication decision support to amplify alerts that are most relevant to the patient at hand while decreasing overall alert volume through a patient-centric approach.

Key Points: 
  • Medication alerts prompt clinicians to review potential safety issues, such as contraindicated drug combinations and drug-allergy conflicts.
  • FDB PatientFirst solutions, which include FDB Targeted Medication Warnings™ and FDB Pharmacogenomic CDS , draw upon patient data and trusted FDB drug data to help narrow the instances when these alerts will fire in the electronic health record.
  • FDB CDS Analytics™ , a capability offered within FDB Targeted Medication Warnings, helps health systems identify alerts for optimization based on the frequency of clinician override or acceptance, and to monitor the performance of alerts.
  • The FDB team will be on hand at booth #1920 in the HIMSS23 Exhibit Hall to answer attendees' questions and discuss their organizations' medication decision support challenges.